Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia 54Myelodysplastic Syndromes 41Lymphoma, Non-Hodgkin 15Congenital Abnormalities 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma 12Recurrence 11Leukemia, Myelomonocytic, Chronic 11Hodgkin Disease 11Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Megakaryoblastic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Biphenotypic, Acute 9Hematologic Neoplasms 9Neoplasms 7Anemia, Refractory, with Excess of Blasts 7Multiple Myeloma 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Graft vs Host Disease 5Burkitt Lymphoma 5Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4

Interventions

fludarabine phosphate 4fludarabine 3Thiotepa 3Melphalan 3Cyclophosphamide 3Whole-Body Irradiation 2Busulfan 2Alemtuzumab 2AP 1903 reagent 2Tacrolimus 1Range of Motion, Articular 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Imagery, Psychotherapy 1Clofarabine 1Bone Marrow Transplantation 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Sickle Cell × Clofarabine × Other hematologic neoplasm × Clear all
NCT03609814 2021-10-04

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

University of California, San Francisco

Completed
30 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡